{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-000037","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.898230+00:00","generated_at":"2026-05-28T08:25:44.092692+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Renovaro signs binding LOI to buy Predictive Oncology; preferred stock valued at $3/share","bullets":["POAI shareholders to receive new Renovaro preferred stock in 1:1 exchange; preferred stock redeemable at $3.00 per share after 18 months.","Deal conditions include minimum $15M fundraising by Renovaro and POAI shareholder approval; definitive agreement due by Feb 28, 2025.","If POAI warrants not exercised by Jan 15, Renovaro will buy up to 2.33M POAI common shares at $1.07 each.","Transaction provides access to POAI's biobank of 150,000 tumor specimens and AI platform with 92% drug-response accuracy.","Combined entity aims to launch decision-support platform for oncologists in 2025, integrating multi-omic diagnostics and drug discovery."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-000037","json":"https://secwatch.observer/filing/0001731122-25-000037.json","markdown":"https://secwatch.observer/filing/0001731122-25-000037.md","text":"https://secwatch.observer/filing/0001731122-25-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000037/0001731122-25-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000037/e6266_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T08:25:44.092692+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}